These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1719639)

  • 21. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
    Darius H; Erbel R; Belz GG; Meyer J
    Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties.
    Stassen JM; Lambeir AM; Matthyssens G; Ripka WC; Nyström A; Sixma JJ; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):646-54. PubMed ID: 8585001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
    Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a bioassay to determine serum levels of dextran sulfate and pentosan polysulfate, two potent inhibitors of human immunodeficiency virus.
    Witvrouw M; Baba M; Balzarini J; Pauwels R; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):343-7. PubMed ID: 1690285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphate.
    Giedrojć J; Radziwon P; Klimiuk M; Bielawiec M; Breddin HK; Kłoczko J
    J Physiol Pharmacol; 1999 Mar; 50(1):111-9. PubMed ID: 10210159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs and herbal remedies that affect blood clotting.
    Wynn RL; Bergman SA
    Gen Dent; 2002; 50(6):484-8, 490. PubMed ID: 12572177
    [No Abstract]   [Full Text] [Related]  

  • 28. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
    Demir M; Iqbal O; Untch B; Hoppensteadt DA; Gaikwad BS; Fareed J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
    Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B
    Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low molecular weight heparins. Implications in anesthesia and resuscitation].
    Llau JV; Hoyas L; Ezpeleta J; García-Polit J; Barberá M; Santes MJ
    Rev Esp Anestesiol Reanim; 1997 Feb; 44(2):70-8. PubMed ID: 9148359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.
    Wong PC; Quan ML; Crain EJ; Watson CA; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2000 Jan; 292(1):351-7. PubMed ID: 10604970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic profile of the antithrombotic and bleeding actions of sulfated lactobionic acid amides.
    Raake W; Klauser RJ; Meinetsberger E; Zeller P; Elling H
    Semin Thromb Hemost; 1991; 17 Suppl 1():129-35. PubMed ID: 2068566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherosclerosis and hemostasis.
    Ulutin ON
    Semin Thromb Hemost; 1986 Apr; 12(2):156-74. PubMed ID: 3526556
    [No Abstract]   [Full Text] [Related]  

  • 37. [Allergic thrombopenia induced by heparin or pentosan polysulfate].
    Bayle J; Chichmanian RM; Caramella A; Mignot G; Spreux A; Samat C; Macci P
    Therapie; 1986; 41(5):339-43. PubMed ID: 2433783
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of fibrinolysis by polyanions in human plasma.
    Klauser RJ
    Thromb Haemost; 1988 Oct; 60(2):324-7. PubMed ID: 2464201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.
    Baba M; Schols D; Pauwels R; Nakashima H; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):493-9. PubMed ID: 1691288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.